December 2016 in “Anales del sistema sanitario de Navarra” Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.
April 2016 in “Expert opinion on orphan drugs” There are various treatment options for frontal fibrosing alopecia.
December 2015 in “Actas Dermo-Sifiliográficas” Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.
July 2015 in “Journal of the Dermatology Nurses’ Association” A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.
May 2015 in “Journal of the American Academy of Dermatology” Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.
February 2013 in “Journal of the American Academy of Dermatology” March 2005 in “Journal of the American Academy of Dermatology” Cosmetic treatments can replenish key amino acids in damaged hair, improving its strength and appearance.
January 2023 in “Dermatologic Therapy” Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.
July 2022 in “Journal of Cosmetic Dermatology” Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.
12 citations
,
September 2018 in “Journal of Drug Delivery Science and Technology” The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.
October 2023 in “Journal of cystic fibrosis”
4 citations
,
October 2012 in “Archives of Dermatology” Hair diameter diversity is a key sign for diagnosing and managing male pattern baldness.
18 citations
,
November 2012 in “Australasian Journal of Dermatology” A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.
17 citations
,
June 2016 in “Australasian Journal of Dermatology” Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.
2 citations
,
May 2017 in “Journal of the American Academy of Dermatology”
1 citations
,
April 2024 in “Dermatology Practical & Conceptual” Hair loss in male frontal fibrosing alopecia may spare areas covered by a wristwatch.
1 citations
,
January 2018 in “Medical Science and Discovery” The document's conclusion cannot be provided as the content is not available for parsing.
27 citations
,
May 2016 in “British journal of dermatology/British journal of dermatology, Supplement” May 2025 in “International Journal of Dermatology”
January 2015 in “Hair transplant forum international” The document's conclusion cannot be provided because the content is not available.
December 2024 in “JAAD International” 3 citations
,
November 2024 in “Journal of the European Academy of Dermatology and Venereology” May 2025 in “Journal of the European Academy of Dermatology and Venereology” 62 citations
,
May 2016 in “British journal of dermatology/British journal of dermatology, Supplement” January 2026 in “Journal of the American Academy of Dermatology” This retrospective cohort study using the TriNetX network investigated the potential risk of osteoporosis or osteopenia in women with androgenetic or frontal fibrosing alopecia treated with 5-alpha reductase inhibitors (5-ARIs), such as finasteride and dutasteride. Despite theoretical concerns that these treatments could negatively impact bone mineral density due to their mechanism of reducing dihydrotestosterone, the study found no elevated risk for osteoporosis or osteopenia among the women treated with 5-ARIs. This finding provides important evidence for the skeletal safety of long-term 5-ARI therapy in women, addressing a significant knowledge gap and supporting evidence-based prescribing practices.
October 2025 in “Lasers in Medical Science” July 2022 in “British Journal of Dermatology”
72 citations
,
July 2008 in “Dermatologic Therapy” CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.